From geopolitical disruption and climate risk to demand volatility and therapeutic complexity, today’s pharmaceutical supply chains are being stress-tested in ways few organizations were designed to handle. For large, global manufacturers, resilience is no longer a contingency plan, it is a core leadership mandate. Panelists will share how their organization is strengthening resilience across a complex, global network and moving beyond reactive risk management toward proactive preparedness. The conversation will explore how leaders are identifying vulnerabilities, building flexibility into operating models, and making deliberate trade-offs between efficiency, redundancy, and responsiveness to ensure continuity of supply and patient access. Rather than focusing on individual tools or initiatives, this session centers on the leadership decisions, governance models, and cultural shifts required to embed resilience into everyday operations—so organizations are better equipped not just to respond to disruption, but to absorb it and emerge stronger.

• Redefine resilience beyond risk mitigation to include adaptability, continuity, and long-term performance
• Identify where to build flexibility, buffers, and optionality across global supply networks
• Balance efficiency, cost, and resilience in an environment of persistent uncertainty
• Lead organizational and cultural shifts that make resilience a sustained capability, not a one-time response

In an era defined by volatility, complexity, and rising expectations for resilience and service, visibility has emerged as the critical foundation of a truly end-to-end supply chain. Yet for many pharma organizations, visibility remains fragmented and trapped within functions, systems, or partners, limiting its impact on real decision-making and execution. This keynote panel brings together senior supply chain and operations leaders to explore how they are elevating visibility from a monitoring capability to a strategic enabler of integrated operating models. Panelists will discuss how real-time, shared visibility across planning, manufacturing, and distribution is reshaping how decisions are made, how teams collaborate, and how organizations respond to disruption. The conversation will focus on how leading companies are using visibility to break down silos, align functions, and drive faster, more confident, and more patient-centric outcomes across the value chain.

• Move from fragmented tracking to shared, real-time visibility that supports end-to-end decision-making
• Use visibility to redesign operating models, reduce latency, and improve cross-functional alignment
• Translate visibility into action through clearer governance, accountability, and execution pathways

AI continues to dominate supply chain conversations, but separating hype from real, measurable impact remains a challenge. This rapid-fire use case showcase brings together pharma leaders who are applying AI in meaningful, operational ways across forecasting, planning, exception detection, quality automation, and more. Each panelist will walk through a concrete example of AI implementation, sharing the problem they set out to solve, what worked (and what didn’t), the measurable outcomes they achieved, and one visual “show-and-tell” takeaway attendees can apply immediately. This is a practical, candid look at AI that moves beyond buzzwords and into real execution.

• Evaluate AI opportunities by grounding them in real operational pain points, measurable business cases, and clear success criteria
• Apply lessons from live implementations, including pitfalls, scalability challenges, and change-management needs, to strengthen your own AI roadmap
• Leverage proven AI use cases and visual takeaways to accelerate forecasting accuracy, streamline planning, and enhance exception-management performance